For hospital-acquired pneumonia with risk of Pseudomonas and MRSA, which treatment combination is commonly used?

For hospital-acquired pneumonia with risk of Pseudomonas and MRSA, which treatment combination is commonly used?

• A. Piperacillin-tazobactam and vancomycin
• B. Ceftriaxone and azithromycin
• C. Ampicillin-sulbactam plus clindamycin
• D. Levofloxacin plus metronidazole

Answer: (A)

Covering hospital-acquired pneumonia when there’s risk for both Pseudomonas and MRSA requires a regimen that targets both organisms. Piperacillin-tazobactam provides strong anti-pseudomonal activity, addressing Pseudomonas and many other gram-negative bacteria. Vancomycin adds MRSA coverage. Together, they offer broad initial coverage appropriate for severe HAP with risk factors for resistant organisms, until culture results allow narrowing. The other options don’t reliably cover both pathogens. Ceftriaxone plus azithromycin lacks consistent Pseudomonas coverage and does not reliably cover MRSA. Ampicillin-sulbactam with clindamycin may cover some gram-positives and anaerobes but generally misses MRSA and has limited Pseudomonas activity. Levofloxacin with metronidazole can cover Pseudomonas but provides incomplete MRSA coverage, and metronidazole is unnecessary for typical pneumonia without anaerobic involvement.

Covering hospital-acquired pneumonia when there’s risk for both Pseudomonas and MRSA requires a regimen that targets both organisms. Piperacillin-tazobactam provides strong anti-pseudomonal activity, addressing Pseudomonas and many other gram-negative bacteria. Vancomycin adds MRSA coverage. Together, they offer broad initial coverage appropriate for severe HAP with risk factors for resistant organisms, until culture results allow narrowing.

The other options don’t reliably cover both pathogens. Ceftriaxone plus azithromycin lacks consistent Pseudomonas coverage and does not reliably cover MRSA. Ampicillin-sulbactam with clindamycin may cover some gram-positives and anaerobes but generally misses MRSA and has limited Pseudomonas activity. Levofloxacin with metronidazole can cover Pseudomonas but provides incomplete MRSA coverage, and metronidazole is unnecessary for typical pneumonia without anaerobic involvement.